IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Q-Line Biotech IPO is a Book Building IPO listing on NSE EMERGE exchange, with an ipo size of ₹ [●] Cr. The company is based in Lucknow and caters to Healthcare sector. Hem Securities , Share India Capital Services are the merchant bankers of Q-Line Biotech IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2025. Q-Line Biotech IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
29.94 cr.
Sector: Healthcare
SME
IPO so far:
51
Merchant Banker:
Hem Securities
SME
IPO by BRLM so far:
137
City:
Lucknow
SME
IPO so far:
4
Revenue (annualised):
₹
313.78
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 19.08x
Q-Line Biotech IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
| Particulars | Amount |
|---|---|
| Repayment of certain borrowing availed by our Company, in part or full | 90 |
| General Corporate Purpose | [●] |
Hem Securities Limited is the book-running lead manager of the Q-Line Biotech IPO. Purva Sharegistry India Private Limited is the Registrar for Q-Line Biotech IPO.
Q-Line Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Q-Line Biotech IPO, based in Lucknow, operates in the Healthcare sector with a focus on Engaged in the business of developing, manufacturing and marketing of diverse range of reagents. The company is launching its SME Upcoming IPO on the NSE EMERGE exchange, using the Book Building Issue method. Q-Line Biotech IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Q-Line Biotech IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Q-Line Biotech IPO allotment status on the registrars website, Purva Sharegistry India Private Limited . Q-Line Biotech IPO refund dates are [●].
Q-Line Biotech IPO is expected to be listed on [●].
The upper price band for the Q-Line Biotech IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Q-Line Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Q-Line Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Q-Line Biotech IPO is finalised.
The merchant banker for Q-Line Biotech IPO is Hem Securities Limited , Share India Capital Services Private Limited . Hem Securities Limited , Share India Capital Services Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Q-Line Biotech IPO RHP for further details.
The registrar for Q-Line Biotech IPO is Purva Sharegistry India Private Limited . Investors can go to Purva Sharegistry India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Q-Line Biotech IPO through their official website or helpline.
Q-Line Biotech IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 29.94 Cr.
Sector: Healthcare
SME
IPO so far:
51
Merchant Banker:
Hem Securities
SME
IPO by BRLM so far:
137
City:
Lucknow
SME
IPO so far:
4
Revenue (annualised):
₹ 313.78 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 19.08x
Q-Line Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Q-Line Biotech Financial Review Page
Merchant Banker(s) of Q-Line Biotech IPO: Hem Securities Limited , Share India Capital Services Private Limited
Q-Line Biotech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Q-Line Biotech IPO listed at a listing price of against the offer price of .
The current market price of Q-Line Biotech is .
Why Us?
